Effect of tresperimus on in vitro human cord blood CD34+ cell differentiation

Haematologia

Volumn 31, Issue 2, 2001, Pages 139-146

  El Marsafy, S ^a   Dutartre, P ^a   Gluckman, E ^a  

^a UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

Cord blood; Hematopoietic stem cell; Immunosuppression; Transplantation

Indexed keywords

15 DEOXYSPERGUALIN; CD4 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LF 08 0299; TRESPERIMUS; UNCLASSIFIED DRUG;

ALLOGENIC BONE MARROW TRANSPLANTATION; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CLINICAL STUDY; CLONOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG WITHDRAWAL; ERYTHROPOIESIS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LETHALITY; MEGAKARYOPOIESIS; MOUSE; MYELOPOIESIS; NONHUMAN; RECIPIENT; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; APOPTOSIS; CARBAMATES; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FETAL BLOOD; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; THROMBOPOIETIN;

EID: 0035207582     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: 10.1163/15685590152492945     Document Type: Article

References (20)

1. A new antitumor antibiotic, spergualin: Isolation and antitumor activity
2. Immunosuppressive activities of 15-deoxyspergualin in animals
3. Prophylactic use of a new immunosuppressive agent, deoxyspergualin, in patients with kidney transplantation from ABO-incompatible or preformed antibody-positive donors
4. Deoxyspergualin for liver graft rejection
5. A novel rescue drug, 15-deoxyspergualin. First clinical trials for recurrent graft rejection in renal recipients
6. Protection from experimental autoimmune thyroiditis in CBA mice with the novel immunosuppressant deoxyspergualin
7. Inhibitory action of deoxyspergualin on effect/memory T cell generation during Hymenolepis nana infection in mice
8. Effects of leflunomide and deoxyspergualin in the guina pig rat cardiac model of delayed xenograft rejection: Suppression of B cell and C-C chemokine responses but not induction macrophage lectin
9. Unique action of immunosuppressive agent, deoxyspergualin, on hematopoiesis in mice
10. Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299
11. Tolerance in a rat cardiac allograft model after short-term treatment with LF 08-0299. Absence of clonal deletion and evidence of CD4+ suppressor cells
12. LF08-0299 induces tolerance after short-term treatment in a fully major histocompatibility mismatched rat cardiac allograft model
13. Structure-immunosuppressive activity relationships of new analogues of 15-deoxyspergualin. 2. Structural modifications of the spermidine moiety
14. In vitro study of deoxymethyl spergualin on functions of lymphocytes and bone marrow cells from healthy volunteers
15. Hematological effects of the new immunosuppressive drug 15-deoxyspergualin
16. The immunosuppressant 15-deoxyspergualin reveals commonality between pre-T and pre-B cell differentiation
17. Effect of 15-deoxyspergualin in vitro and in vivo on cytokine gene expression
18. Effect of deoxyspergualin on hematopoiesis: Studies of murine hematopoietic progenitor cell and peripheral blood cell levels
19. Recombinant human thrombopoietin (TPO) stimulates erythropoiesis by inhibiting erythroid progenitor cell apoptosis
20. Thrombopoietin expands erythroid, granulocyte-macrophage and megakaryocytic progenitor cells in normal and myelosuppressed mice